Stud
y Finds: Drug typically used in cancer therapy emerges as powerful anti-aging remedy
Rapamycin is a cell growth inhibitor and immunosuppressant that people normally take while undergoing cancer treatment or after receiving an organ transplant.
A team from the Max Planck Institute for Biology of Ageing, however, notes that the drug is also a promising anti-aging formula.
Studies involving animals have found that low doses of rapamycin can extend life by preventing age-related changes in the intestines. Until now, however, scientists have looked at this drug as something patients would need to take for the rest of their lives.
Study Finds: Drug typically used in cancer therapy emerges as powerful anti-aging remedy.